欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/0115/003
药品名称Detimedac 500 mg
活性成分
    • dacarbazine 500.0 mg
剂型Powder for solution for infusion
上市许可持有人Medac Gesellschaft für klinische Spezialpräparate m.b.H. Fehlandtstr. 3 D-20354 Hamburg Germany
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Denmark (DK)
      Dacarbazine 500 mg
    • Belgium (BE)
      Dacarbazine 500 mg
    • Netherlands (NL)
      Dacarbazine 500 mg Medac
    • United Kingdom (Northern Ireland) (XI)
      Detimedac / Dacarbazine medac 500 mg
    • Ireland (IE)
      Dacarbazine 500 mg
    • Austria (AT)
      Dacarbazine medac 500 mg - Pulver zur Herstellung einer Infusionslösung
    • Spain (ES)
      Dacarbazina Medac 500 mg polvo para solución para perfusión
    • Portugal (PT)
      DACARBAZINA
    • Italy (IT)
      DACARBAZINE MEDAC
    • Sweden (SE)
      Dacarbazine medac
许可日期1997/10/08
最近更新日期2024/08/07
药物ATC编码
    • L01AX04 dacarbazine
申请类型
  • TypeLevel1：New Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Article 4.8 Di 65/65
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase